Andrew A. Hindman - SVP, CHIEF FINANCIAL OFFICER at Theravance Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Financial Officer
Stock Symbol
TBPH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew A. Hindman since 11/12/2023

Holdings reported by Andrew A. Hindman for Theravance Biopharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 385K $3.96M $10.29 Nov 20, 2022 Direct

Transactions reported by Andrew A. Hindman for Theravance Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.